Steroid hormone profile of canine inflammatory mammary carcinoma: A preliminary study

Journal of Steroid Biochemistry and Molecular Biology

Volumn 84, Issue 2-3, 2003, Pages 211-216

  Pena L ^a   Silvan G ^a   Perez Alenza M D ^a   Nieto, A ^a   Illera, J C ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Androstenedione; Canine mammary inflammatory carcinoma; Dehydroepiandrosterone; Estradiol; Estrone sulphate; Progesterone; Steroid hormones

Indexed keywords

ANDROSTENEDIONE; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); ESTRADIOL; ESTRONE SULFATE; PRASTERONE; PROGESTERONE; STEROID HORMONE;

ANIMAL TISSUE; AUTOCRINE EFFECT; BENIGN TUMOR; BREAST CARCINOMA; BREAST DYSPLASIA; CANCER GROWTH; CANCER TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DOG; ENZYME IMMUNOASSAY; FEMALE; HORMONE DETERMINATION; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PROTEIN EXPRESSION; TISSUE HOMOGENATE; TISSUE SLICE;

CANIS FAMILIARIS;

EID: 0242669158     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(03)00030-X     Document Type: Conference Paper

References (30)

1. Vermeulen A., Delyspere J.P., Paridaens R. Steroid dynamics in the normal and carcinomatous mammary gland. J. Steroid Biochem. 25:1986;799-802.
2. Killinger D.W., Perel E., Daniilescu D., Kharlip L., Blackstein M.E. Aromatase activity in the breast and other peripheral tissues and its therapeutic regulation. Steroids. 50:1987;523-536.
3. Blankenstein M.A., Van de Ven J., Maitimu-Smeele I., Donker G.H., Chr de Jong P., Daroszewski J., Szymczak J., Milewicz A., Thijssen J.H.H. Intratumoral levels of estrogens in breast cancer. J. Steroid Biochem. Mol. Biol. 69:1999;293-297.
4. Maggiolini M., Carpino A., Bonofiglio D., Pezzi V., Rago V., Marisco S., Picard D., Andò S. The direct proliferative stimulus of dehydroepiandrosterone on MCF7 breast cancer cells is potentiated by overexpression of aromatase. Mol. Cell. Endocrinol. 184:2001;163-171.
5. Liao D.J., Dickson R.B. Roles of androgens in the development, growth, and carcinogenesis of the mammary gland. J. Steroid Biochem. Mol. Biol. 80:2002;175-189.
6. F.A. Tavassoli, Inflammatory Carcinoma, Infiltrating Carcinomas: Special Types, Pathology of the Breast, 2nd ed., McGraw-Hill, New York, 1999, pp. 538-541.
7. Perez-Alenza M.D., Tabanera E., Peña L. Inflammatory mammary carcinoma in dogs: 33 cases (1995-1999). J. Am. Vet. Med. Assoc. 219:2001;1110-1114.
8. Kleer C.G., van Golen K.L., Zhang Y., Wu Z.F., Rubin M.A., Merajver S.D. Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability. Am. J. Pathol. 160(2):2002;579-584.
9. Van Golen K.L., Davies S., Wu Z.F., Wang Y., Bucana C.D., Root H., Chandrasekharappa S., Strawderman M., Ethier S.P., Merajver S.D. A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype. Clin. Cancer Res. 5(9):1999;2511-2519.
10. Van Golen K.L., Davies S., Wu Z.F., Wang Y., Bucana C.D., Root H., Chandrasekharappa S., Strawderman M., Ethier S.P., Merajver S.D. A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype. Clin. Endocrinol. Metab. 81:1996;1460-1464.
11. L. Peña, M.D. Perez-Alenza, A. Rodriguez-Bertos, A. Nieto, Canine inflammatory mammary carcinoma: histopathology, immunohistochemistry and clinical implications of twenty-one cases, Breast Cancer Res. Treat., in press.
12. W. Misdorp, R.W. Else, E. Helmén, T.P. Lipscomb, Histological Classification of Mammary Tumors of the Dog and Cat, Second Series, vol 7, Published by Armed Forces Institute of Pathology and World Health Organization, Washington, 1999.
13. Labrie F., Luu-The V., Labrie C., Simard J. DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology. Frontiers Neuroendocrinol. 22:2001;185-212.
14. Thijssen J.H.H., Blankenstein M.A., Miller W.R., Milewicz A. Estrogens in tissues: uptake from the peripheral circulation or local production. Steroids. 50:1987;1-3.
15. Thijssen J.H.H., Blankenstein M.A., Donker G.H., Daroszewski J. Endogenous steroid hormones and local aromatase activity in the breast. J. Steroid Biochem. Mol. Biol. 39(5B):1991;799-804.
16. Blankenstein M.A., Maitimu-Smeele I., Donker G.H., Daroszewski J., Milewicz A., Thijssen J.H. Tissue androgens and the endocrine autonomy of breast cancer. J. Steroid. Biochem. Mol. Biol. 43(1-3):1992;167-171.
17. Perel E., Davis S., Killinger D.W. Androgen metabolism in male and female breast tissue. Steroids. 37:1981;345-352.
18. Santen R.J., Leszczynski D., Tilson-Mallet N., Feil P.D., Wright C., Manni A.et al. Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versussulfatase pathways. Ann. N. Y. Acad. Sci. 464:1986;126-137.
19. Pasqualini J.R., Gelly C., Nguyen B.L., Vella C. Importance of estrogen sulfates in breast cancer. J. Steroid Biochem. 34:1989;155-163.
20. Pasqualini J.R., Chetrite G., Blacker C., Feinstein M.C., Delalonde L., Talbi M., Maloche C. Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients. J. Clin. Endocrinol. Metab. 81(4):1996;1460-1464.
21. Mady E.A., Ramadan E.E.-D.H., Ossman A.A. Sex steroid hormones in serum and tissue of benign and malignant breast tumors patients. Dis. Markers. 16:2000;151-157.
22. Perel E., Killinger D.W. The metabolism of androstenedione and testosterone to C19 metabolites in normal breast, breast carcinoma and benign prostatic hypertrophy tissue. J. Steroid. Biochem. 29(2):1983;1135-1139.
23. Brignardello E., Cassoni P., Migliardi M., Pizzini A., Di Monaco M., Boccuzzi G., Massobrio M. Dehydroepiandrosterone concentration in breast cancer tissue is related to its plasma gradient across the mammary gland. Breast Cancer Res. Treat. 33(2):1995;171-177.
24. Billich A., Nussbaumer P., Lehr P. Stimulation of MCF-7 breast cancer cell proliferation by estrone sulphate and dehydroepiandrosterone sulphate: inhibition by novel non-steroid sulfatase inhibitors. J. Steroid Biochem. Mol. Biol. 73:2000;225-235.
25. Santen R.J., Samojlik E., Demers L., Badder E. Adrenal of male dog secrets androgens and estrogens. Am. J. Fisiol. 239:1980;109-112.
26. Sasano H., Nagura H., Harada N., Goukon Y., Kimura M. Immunolocalization of aromatase and other steroidogenic encimes in human breast disorders. Hum. Pathol. 25(5):1994;530-535.
27. Chang S., Alderfer J.R., Asmar L., Buzdar A.U. Inflammatory breast cancer survival: the role of obesity and menopausal status at diagnosis. Breast Cancer Res. Treat. 64:2000;157-163.
28. Szymczak J., Milewicz A., Thijssen J.H.H., Blankenstein M.A., Daroszewski J. Concentration of sex steroids in adipose tissue after menopause. Steroids. 63:1998;319-321.
29. Brooks H.L., Mandava N., Pizzi W.F., Shah S. Inflammatory breast carcinoma: a community hospital experience. J. Am. Coll. Surg. 186:1998;622-629.
30. Wilke D., Colwell B., Dewar R. Inflammatory breast carcinoma: comparison of survival of those diagnosed clinically, pathologically, or with both features. Am. Surgeon. 64:1998;428-431.